Different autoantigens are thought to be involved in the pathogenesis of insulin-dependent diabetes mellitus, and they may account for the variation in the clinical presentation of the disease. Sera from patients with autoimmune polyendocrine syndrome type I contain autoantibodies against the 13-cell proteins glutamate decarboxylase and an unrelated 51-kDa antigen. By screening of an expression library derived from rat insulinoma cells, we have identified the 51-kDa protein as aromatic-L-amino-acid decarboxylase (EC 4.1.1.28). In addition to the previously published fulllength cDNA, forms coding for a truncated and an alternatively spliced version were identified. Aromatic L-amino acid decarboxylase catalyzes the decarboxylation of L-5-hydroxytryptophan to serotonin and that of L-3,4-dihydroxyphenylalanine to dopamine. Interestingly, pyridoxal phosphate is the cofactor of both aromatic L-amino acid decarboxylase and glutamate decarboxylase. The biological significance of the neurotransmitters produced by the two enzymes in the 18 cells remains largely unknown.
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The cell-specific destruction of the insulin-producing pancreatic ,B cells in insulin-dependent diabetes mellitus (IDDM) is mediated by autoimmune mechanisms. Glutamate decarboxylase (GAD), an enzyme catalyzing the synthesis of y-aminobutyric acid (GABA) from glutamate, has been identified as a major autoantigen (1) . Autoantibodies against this enzyme are present in up to 80% of the patients with IDDM (2, 3) , and prediabetic individuals often exhibit reactivity against GAD before the appearance of any clinical manifestations of the disease (4) . Patients with IDDM are prone to develop autoimmunity against other organs-e.g., Addison disease and Graves disease (5) . In the rare disease autoimmune polyendocrine syndrome type I (APS I), an autoimmune attack against the parathyroid glands, the adrenal glands, and the gonads begins in childhood (6) , whereas IDDM may occur at a higher age (5, 6) . Nonendocrine symptoms-e.g., chronic mucocutaneous candidiasis, chronic active hepatitis, alopecia, vitiligo, and malabsorption-are also frequent manifestations of the disease (6) . In the adrenal cortex (7) and gonads (8) , cytochrome P450 side-chain cleavage enzyme-the catalyst of the rate-limiting step in the steroid synthesis-is the major autoantigen. GAD is recognized in the insulin-producing f3 cells by a majority of sera from APS I patients (9, 10) . In addition, strong reactivity against a 51-kDa protein of previously unknown identity has been observed in all APS I sera examined (9) . The 51-kDa protein has now been identified by immunoscreening of a cDNA library constructed from a rat insulinoma cell line.t MATERIALS AND METHODS Subjects and Sera. Sera were obtained from seven patients with diagnosed APS I. Clinical characteristics of six of these patients have been described previously (9) . The seventh patient was a 17-year-old woman with candidiasis, hypoparathyroidism, Addison disease, gonadal insufficiency, and hypothyroidism. Normal goat serum was obtained from Dakopatts (Glostrup, Denmark), and a specific rabbit serum against aromatic-L-amino-acid decarboxylase (AADC, EC 4.1.1.28) (anti-AADC) was purchased from Biogenesis (Poole, Dorset, U.K.).
Construction of RINm 5F cDNA Library. The LiCl/urea method (11) was used to prepare total cellular RNA from the rat insulinoma cell line RINm 5F. Cells were cultured in Ham's F12 medium (Nord Vacc, Skarholmen, Sweden) supplemented with nonessential amino acids and 10% fetal calf serum (FCS; Biochrom, Berlin). Poly(A)+ RNA was purified with Oligotex-dT (Qiagen, Chatsworth, CA). cDNA was synthesized and the library in the A ZAP II vector was constructed according to instructions of the supplier (Stratagene), except for size fractionation of the cDNA, which was performed on a continuous 5-20% potassium acetate gradient. Five milliliters of gradient was overlaid with 100 ,ul of 10 mM Tris HCl and 1 mM ethylenediaminetetraacetic acid (EDTA), pH 7.4, containing the synthesized cDNA. After centrifugation for 3 hr at 50,000 rpm (230,000 x g) in an SW 50.1 rotor (Beckman) at 22°C, 0.5-ml fractions were collected and analyzed by electrophoresis in a 1.0% agarose gel. Fractions containing cDNAs larger than 1000 bp were pooled and ligated into A ZAP II. The completed library, containing 4.5 x 106 recombinant clones, was amplified once.
Immunoscreening of the Library. We plated 5 x 105 plaqueforming units (pfu) of the amplified library on Escherichia coli XL-1 at a density of 350 pfu/cm2. After 3.5 hr of culture at 42°C, plates were overlaid with nitrocellulose filters (Hybond C, Amersham) previously soaked with 10 mM isopropyl f-Dthiogalactopyranoside (IPTG; Sigma) and cultured for another 3.5 hr at 37°C. The filters were carefully removed from the plates and washed in 15 ml of 20 mM Tris-HCl, pH 7.5/0.1% gelatin/0.05% Tween-20 (TBS-GT) three times for 5 min. Nonspecific protein binding was blocked with 15 ml of 1% gelatin in 20 mM Tris HCl, pH 7.5, for 1 hr, after which the filters were washed in TBS-GT as above. To reduce unspecific binding of the secondary antibody during color development, the filters were incubated with normal goat serum at a dilution of 1/1000 in TBS-GT for 30 min. After a third wash cycle, filters were incubated overnight with sera diluted 1/5000 in TBS-GT, from one of the patients. Filters were washed in 20 mM Tris HCI, pH 7.5, supplemented with 0.1% gelatin and then incubated with alkaline phosphatase-conjugated goat anti-human IgG for 1.5 hr prior to color development with a p-nitrobluetetrazolium chloride (NBT)/5-bromo-4-chloro-3-Abbreviations: IDDM, insulin-dependent diabetes mellitus; GAD, glutamate decarboxylase; GABA, y-aminobutyric acid; APS I, autoimmune polyendocrine syndrome type I; AADC, aromatic-L-aminoacid decarboxylase; FCS, fetal calf serum. *To whom reprint requests should be addressed.
tThe sequence reported in this paper has been deposited in the GenBank data base (accession no. U31884).
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indoyl phosphate/toluidine (BCIP) system (Bio-Rad). Positive clones were rescreened until pure isolates were obtained. DNA (15) coding for a protein of 480 amino acids with a calculated molecular mass of 54 kDa, whereas clones 10.5 and 10.7 corresponded to forms not previously described (Fig. 1) . Clone (Fig. 1) .
Immunoprecipitation of Rat Islet and RINm 5F Lysates. Immunoprecipitations of isolated [35S]methionine-labeled islets of Langerhans from rats were performed to establish whether the 51-kDa protein and AADC were identical. All sera from patients with APS I precipitated a 51-kDa protein which comigrated with AADC precipitated by a specific anti-AADC serum (Fig. 2 Left) . In accordance with previous data (9), a majority of the sera (5 of 7) also precipitated a doublet of approximately 65 kDa corresponding to GAD. Furthermore, when a lysate from RINm SF cells was precleared with the specific anti-AADC serum, the ability of patient sera to subsequently immunoprecipitate the 51-kDa autoantigen was abolished (Fig. 2 Right) .
Immunoprecipitation of Recombinant AADC. To confirm the identity of the 51-kDa protein, clone 3.1 was ligated into the pBK-CMV vector. After transient expression in COS cells, all APS I sera immunoprecipitated AADC (Fig. 3, lanes a, c, e, and g), while no reactivity was detected in COS cells transfected with the empty vector (Fig. 3, lanes b, d, 
DISCUSSION
It is intriguing that autoantigens in organ-specific autoimmune diseases often are enzymes of key importance for the affected organ (16) . In the present work we show that AADC, in addition to GAD, is a major autoantigen in , cells in APS I. Interestingly, both GAD and AADC are pyridoxal phosphate- and around the pyridoxal phosphate-binding site, Asp-ProHis-Lys (17) . The fact that no relation between reactivities against AADC and GAD was found in individual patients and the observation that an anti-AADC antibody did not crossreact with GAD indicate that there was no cross-reactivity between GAD autoantibodies and AADC.
AADC catalyzes the decarboxylation of aromatic L-amino acids, notably L-3,4-dihydroxyphenylalanine (dopa) and 5-hydroxytryptophan (5-HT), which are intermediates in the synthesis of catecholamine and indolamine neurotransmitters (18) . In Drosophila melanogaster two different forms of AADC have been described, one in the nervous system and the other in the hypoderm (19) . Neuronal and nonneuronal forms of the enzyme have also been observed in the rat (20) (26) . Dopamine and serotonin produced by AADC could be involved in the regulation of insulin synthesis and secretion (27) . It may also be speculated that AADC may decarboxylate unknown regulator molecules (28) .
GAD and AADC are both intracellular enzymes. GAD is mainly found in synaptic-like small vesicles (SLMV; ref. 29) , whereas AADC is located in the cytosol (30) . Since antibodies are directed against antigens on the cell surface, it is unclear how autoantibodies against the intracellular enzymes GAD and AADC could be participating in the pathogenesis of IDDM. Peripheral-blood mononuclear cells from patients with IDDM have been demonstrated to proliferate in vitro on exposure to GAD (31, 32) , indicating a role of cell-mediated immunity. Even though it has been suggested that the initial lesion is likely to be T-cell mediated and the presence of autoantibodies merely reflects 13-cell destruction, as markers of the disease, it cannot be ruled out that autoantibodies do take part in the pathogenesis of IDDM.
It has recently been observed that amino acids 250-273 of GAD 65 show sequence similarity with amino acids 28-50 of the coxsackievirus B protein P2-C (33, 34) . It was proposed that, as a result of this molecular mimicry, cross-reactive T-cell proliferation will occur, leading to autoimmune destruction of the ,B cells. However, we have not been able to find any evidence of molecular mimicry between AADC and any known microorganism upon search of protein data bases.
The fact that AADC and GAD, two important enzymes for the generation of neurotransmitters, act as autoantigens in the islets of Langerhans underlines the neuron-like nature of the 13 cells. In the central nervous system the blood-brain barrier seems to protect these enzymes from an immune attack, except in the rare cases of stiff man syndrome, where autoantibodies against GAD are present in the cerebrospinal fluid (35 
